HPV Action Network

Contact the Network

 

The Network’s Co-Chair, Daniel Kelly, presented the case for gender-neutral HPV vaccination throughout the EU to the Special Committee on Beating Cancer (BECA) at a public hearing at the European Parliament on 2 December 2020. Daniel Kelly emphasised that Europe now has a great opportunity to take a lead globally in eliminating all HPV-caused cancers. His comments were very well-received by MEPs.

Kelly BECAmeeting 600

Daniel Kelly outlined the opportunity for the Europe's Beating Cancer Plan to adopt the inspiring goal of eliminating HPV caused cancers in Europe during the Special Committee on Beating Cancer (BECA) public hearing at the European Parliament on 2 December 2020. More information here and on our Twitter feed here.

BECA members were also sent a copy of the European Cancer Organisation’s major new report, Viral Protection: Achieving the Possible. A Four Step Plan for Eliminating HPV Cancers in Europe. Published in October 2020, this sets out a four-step plan for eliminating HPV cancers in Europe and will form the basis for the Network’s advocacy work over the next year. The report calls for the implementation of gender-neutral HPV vaccination programmes and effective cervical cancer screening programmes in all European countries, the adoption of best-practice treatments for all patients with cancers caused by HPV, and improved HPV education and awareness programmes for both patients and health professionals.

The World Health Organization launched a new global strategy for cervical cancer elimination in November 2020. In response, the HPV Action Network is urging Europe to play a world-leading role by embracing and enhancing this inspiring agenda by seizing the opportunity to make the elimination of all the cancers caused by HPV an objective shared by all European countries.

We are calling on the European Commission to take action on HPV in its new Europe’s Beating Cancer Plan, due for publication January 2021. The HPV Action Network also plans to focus on those countries which are falling behind, especially in respect of vaccination and screening.

summit2020 hpv panel 800

Panel discussion at the European Cancer Summit 2020 session “Viral Protection: Achieving the Possible. The elimination of HPV cancers in Europe”.

The HPV Action Network hosted a session “Viral Protection: Achieving the Possible. The elimination of HPV cancers in Europe”  at the European Cancer Summit 2020 on 18 & 19 November. The session was very well-received and generated significant feedback via Chat. Two resolutions were passed calling for action to tackle the disruption caused to cervical cancer screening programmes by the COVID-19 pandemic and to address the impact of anti-vaccination misinformation on public confidence in HPV vaccination. More information about the HPV session and the resolutions is available here.

  • Find out more on the 2020 European Cancer Summit here.
  • Watch the session recordings and access valuable resources here.
  • Read the report of the Summit here.

The HPV Action Network was established following the 2019 European Cancer Summit. At this meeting, over 300 cancer community stakeholders agreed this resolution: ‘By 2030, effective strategies to eliminate cancers caused by HPV as a public health problem should be implemented in all European countries’.

The Summit was soon followed by the launch of the  European Cancer Organisation’s HPV Action Network at the European Parliament in Brussels in December 2019 with the support of Professor Véronique Trillet-Lenoir MEP (Renew Europe, France), Vice-Chair of the MEPs Against Cancer Group. The Network brings together organisations and individuals from a wide range of backgrounds who share the ambitious but highly achievable goal of eliminating all the cancers and other diseases caused by HPV across the European region.

HPV (human papillomavirus) is a very common sexually transmitted infection that causes 4.5% of all cancers in men and women worldwide and about 2.5% of cancers in Europe. Cervical cancer is the most commonly-caused cancer but HPV is also responsible for a high proportion of anal, penile, vaginal, vulval and oropharyngeal cancers. Up to 20-30% of HPV cancers affect men. HPV also causes genital warts and recurrent respiratory papillomatosis (RRP), a rare but disabling breathing condition.

 

Follow the HPV Action Network’s activities on Twitter @HPVAction

To find out more about this Network, or support our work, please contact us here.

Other networks